Vernus BioLab (Taiwan) Co., Ltd.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
ReAIX process optimization platform integrates artificial intelligence and quantum computing to deliver breakthrough manufacturing optimization solutions for pharmaceutical production. From improving efficiency to significantly reducing costs, ReAIX injects intelligent capabilities into manufacturing workflows to ensure quality and competitiveness. The platform provides manufacturing solutions across all drug modalities, ranging from biologics to small-molecule drugs, enabling scalable and high-efficiency production.
Founded Year
2025
Unified Business No.
60796415
Status
Active
Number of Employees
12
Total Paid-in
Capital
100,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Vernus BioLab (Vernus AI) integrates quantum computing and generative AI to transform pharmaceutical R&D and manufacturing. It aims to break traditional drug development bottlenecks, enhance production capabilities, and build resilient next-generation intelligent pharmaceutical systems.
